Skin disorders in patients with primary immunodeficiencies

Natasha Klimas, Travis W. Vandergriff

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Primary immunodeficiencies (PIDs) are conditions caused by molecular defects in the genes required for normal immune function. PIDs are rare, with a prevalence of approximately 1 in 25,000. Though much remains to be explored in the field of PIDs, over 185 distinct defects have been described. Infections are generally the most pronounced feature of PIDs. However, PIDs have many non-infectious sequelae also. Cutaneous involvement, infectious and non-infectious, is prominent in many cases. In fact, cutaneous manifestations precede immunologic diagnosis in 79 % of PID patients. PIDs are subject to wide clinical, immunological, and genetic heterogeneity. Different mutations in the same gene may yield variable phenotypes. This chapter will detail the clinical manifestations, genetics and pathophysiology, diagnosis, and management of selected PIDs with a special focus on those with historically prominent cutaneous findings.

Original languageEnglish (US)
Title of host publicationSkin Diseases in the Immunocompromised
PublisherSpringer-Verlag London Ltd
Pages31-44
Number of pages14
Volume9781447164791
ISBN (Print)9781447164791, 1447164784, 9781447164784
DOIs
StatePublished - May 1 2014

Fingerprint

Skin Manifestations
Skin
Immunologic Tests
Genetic Heterogeneity
Genes
Phenotype
Mutation
Infection

Keywords

  • Agammaglobunemia
  • Autoimmunity
  • Autosomal recessive
  • Combined immunodeficiencies
  • Complement deficiencies
  • Granuloma
  • Iga deficiency
  • Phagocytic defects

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Klimas, N., & Vandergriff, T. W. (2014). Skin disorders in patients with primary immunodeficiencies. In Skin Diseases in the Immunocompromised (Vol. 9781447164791, pp. 31-44). Springer-Verlag London Ltd. https://doi.org/10.1007/978-1-4471-6479-1_3

Skin disorders in patients with primary immunodeficiencies. / Klimas, Natasha; Vandergriff, Travis W.

Skin Diseases in the Immunocompromised. Vol. 9781447164791 Springer-Verlag London Ltd, 2014. p. 31-44.

Research output: Chapter in Book/Report/Conference proceedingChapter

Klimas, N & Vandergriff, TW 2014, Skin disorders in patients with primary immunodeficiencies. in Skin Diseases in the Immunocompromised. vol. 9781447164791, Springer-Verlag London Ltd, pp. 31-44. https://doi.org/10.1007/978-1-4471-6479-1_3
Klimas N, Vandergriff TW. Skin disorders in patients with primary immunodeficiencies. In Skin Diseases in the Immunocompromised. Vol. 9781447164791. Springer-Verlag London Ltd. 2014. p. 31-44 https://doi.org/10.1007/978-1-4471-6479-1_3
Klimas, Natasha ; Vandergriff, Travis W. / Skin disorders in patients with primary immunodeficiencies. Skin Diseases in the Immunocompromised. Vol. 9781447164791 Springer-Verlag London Ltd, 2014. pp. 31-44
@inbook{9757a238aa454f2cb285a4d1a692f6f2,
title = "Skin disorders in patients with primary immunodeficiencies",
abstract = "Primary immunodeficiencies (PIDs) are conditions caused by molecular defects in the genes required for normal immune function. PIDs are rare, with a prevalence of approximately 1 in 25,000. Though much remains to be explored in the field of PIDs, over 185 distinct defects have been described. Infections are generally the most pronounced feature of PIDs. However, PIDs have many non-infectious sequelae also. Cutaneous involvement, infectious and non-infectious, is prominent in many cases. In fact, cutaneous manifestations precede immunologic diagnosis in 79 {\%} of PID patients. PIDs are subject to wide clinical, immunological, and genetic heterogeneity. Different mutations in the same gene may yield variable phenotypes. This chapter will detail the clinical manifestations, genetics and pathophysiology, diagnosis, and management of selected PIDs with a special focus on those with historically prominent cutaneous findings.",
keywords = "Agammaglobunemia, Autoimmunity, Autosomal recessive, Combined immunodeficiencies, Complement deficiencies, Granuloma, Iga deficiency, Phagocytic defects",
author = "Natasha Klimas and Vandergriff, {Travis W.}",
year = "2014",
month = "5",
day = "1",
doi = "10.1007/978-1-4471-6479-1_3",
language = "English (US)",
isbn = "9781447164791",
volume = "9781447164791",
pages = "31--44",
booktitle = "Skin Diseases in the Immunocompromised",
publisher = "Springer-Verlag London Ltd",

}

TY - CHAP

T1 - Skin disorders in patients with primary immunodeficiencies

AU - Klimas, Natasha

AU - Vandergriff, Travis W.

PY - 2014/5/1

Y1 - 2014/5/1

N2 - Primary immunodeficiencies (PIDs) are conditions caused by molecular defects in the genes required for normal immune function. PIDs are rare, with a prevalence of approximately 1 in 25,000. Though much remains to be explored in the field of PIDs, over 185 distinct defects have been described. Infections are generally the most pronounced feature of PIDs. However, PIDs have many non-infectious sequelae also. Cutaneous involvement, infectious and non-infectious, is prominent in many cases. In fact, cutaneous manifestations precede immunologic diagnosis in 79 % of PID patients. PIDs are subject to wide clinical, immunological, and genetic heterogeneity. Different mutations in the same gene may yield variable phenotypes. This chapter will detail the clinical manifestations, genetics and pathophysiology, diagnosis, and management of selected PIDs with a special focus on those with historically prominent cutaneous findings.

AB - Primary immunodeficiencies (PIDs) are conditions caused by molecular defects in the genes required for normal immune function. PIDs are rare, with a prevalence of approximately 1 in 25,000. Though much remains to be explored in the field of PIDs, over 185 distinct defects have been described. Infections are generally the most pronounced feature of PIDs. However, PIDs have many non-infectious sequelae also. Cutaneous involvement, infectious and non-infectious, is prominent in many cases. In fact, cutaneous manifestations precede immunologic diagnosis in 79 % of PID patients. PIDs are subject to wide clinical, immunological, and genetic heterogeneity. Different mutations in the same gene may yield variable phenotypes. This chapter will detail the clinical manifestations, genetics and pathophysiology, diagnosis, and management of selected PIDs with a special focus on those with historically prominent cutaneous findings.

KW - Agammaglobunemia

KW - Autoimmunity

KW - Autosomal recessive

KW - Combined immunodeficiencies

KW - Complement deficiencies

KW - Granuloma

KW - Iga deficiency

KW - Phagocytic defects

UR - http://www.scopus.com/inward/record.url?scp=84930171850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930171850&partnerID=8YFLogxK

U2 - 10.1007/978-1-4471-6479-1_3

DO - 10.1007/978-1-4471-6479-1_3

M3 - Chapter

AN - SCOPUS:84930171850

SN - 9781447164791

SN - 1447164784

SN - 9781447164784

VL - 9781447164791

SP - 31

EP - 44

BT - Skin Diseases in the Immunocompromised

PB - Springer-Verlag London Ltd

ER -